Conference
A phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.
Authors
Halmos B; Bokar JA; Fu P; Adelstein DJ; Juergens RA; Rodal MB; Dowlati A
Volume
29
Pagination
pp. e14644-e14644
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2011
DOI
10.1200/jco.2011.29.15_suppl.e14644
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X